4 Firms Advise On $3.4B Apollo, Bayer Contraceptives Deal
Apollo Global Management has agreed to pay €3 billion ($3.4 billion) for a minority stake in Bayer's long-acting reversible contraceptive business, according to a joint announcement Friday. ...To view the full article, register now.
Already a subscriber? Click here to view full article